The United States of America, yesterday, dashed the hope of an early cure for Ebola Virus victims in Nigeria when it refused to share the trial drug with Nigeria. US President Barak Obama says it would be premature to share the experimental drug with Africa.
The Federal Government had earlier reached out to the United States Centre for Disease Control and Prevention, CDC, in Atlanta, to request for the drug for treatment of EVD affected persons in Nigeria, but President Obama turned down the request, saying it would be far more beneficial to focus on prevention instead.
Nigeria recorded its first Ebola Virus disease fatality on Tuesday when one of the nurses who was one of the primary contacts of the American-Liberian, Patrick Sawyer, passed on. The doctor who treated Sawyer, who died in the country after flying into Lagos, is now ill with Ebola and six other primary contacts are currently ill with the disease in a Lagos hospital where they are quarantined.
Minister of Health, Professor Onyebuchi Chukwu and Minister of Information, Mr. Labaran Maku had disclosed on Wednesday after the Federal Executive Council meeting in Abuja that the Federal Government was awaiting the response of the request it made to the CDC on Tuesday.
Addressing the 50 African leaders at the US-African Summit in Washington, President Obama stated that it is “premature” to send an experimental medicine for the treatment of Ebola to West Africa, as he lacked enough information to approve the drug that was already being used on two American aid workers whose conditions were said to have improved by varying degrees.
“We’ve got to let the science guide us and I don’t think all the information is in on whether this drug is helpful. The Ebola virus, both currently and in the past, is controllable if you have a strong public health infrastructure in place.
“The countries affected are the first to admit that what’s happened here is the public health systems have been overwhelmed. They weren’t able to identify and then isolate cases quickly enough.
“As a consequence, it spread more rapidly than has been typical with the periodic Ebola outbreaks that occurred previously,” he remarked.
Palliative
As a palliative, President Obama announced plans by the US to spend $110 million annually, for three to five years, totall ing $330-$550 million, to help African nations develop rapid reaction peacekeeping forces.
The Ebola virus causes viral hemorrhagic fever, which refers to a group of viruses that affect multiple organ systems in the body and are often accompanied by bleeding.
The experimental medicine is a three-mouse monoclonal antibody, meaning that mice were exposed to fragments of the Ebola virus and then the antibodies generated within the mice’s blood were harvested to create the medicine. It works by preventing the virus from entering and infecting new cells.
Developed by a San Diego Company, Mapp Biopharmaceutical, the experimental serum had never been tried before on human beings but had shown promise in small experiments with monkeys. Company documents show that four monkeys infected with Ebola survived after being given the therapy within 24 hours after infection.
In the monkeys, the experimental serum had been given within 48 hours of infection. Two of four other monkeys that started therapy within 48 hours after infection also survived. One monkey that was not treated died within five days of exposure to the virus.
Source:Nigeria recorded its first Ebola Virus disease fatality on Tuesday when one of the nurses who was one of the primary contacts of the American-Liberian, Patrick Sawyer, passed on. The doctor who treated Sawyer, who died in the country after flying into Lagos, is now ill with Ebola and six other primary contacts are currently ill with the disease in a Lagos hospital where they are quarantined.
Minister of Health, Professor Onyebuchi Chukwu and Minister of Information, Mr. Labaran Maku had disclosed on Wednesday after the Federal Executive Council meeting in Abuja that the Federal Government was awaiting the response of the request it made to the CDC on Tuesday.
Addressing the 50 African leaders at the US-African Summit in Washington, President Obama stated that it is “premature” to send an experimental medicine for the treatment of Ebola to West Africa, as he lacked enough information to approve the drug that was already being used on two American aid workers whose conditions were said to have improved by varying degrees.
“We’ve got to let the science guide us and I don’t think all the information is in on whether this drug is helpful. The Ebola virus, both currently and in the past, is controllable if you have a strong public health infrastructure in place.
“The countries affected are the first to admit that what’s happened here is the public health systems have been overwhelmed. They weren’t able to identify and then isolate cases quickly enough.
“As a consequence, it spread more rapidly than has been typical with the periodic Ebola outbreaks that occurred previously,” he remarked.
Palliative
As a palliative, President Obama announced plans by the US to spend $110 million annually, for three to five years, totall ing $330-$550 million, to help African nations develop rapid reaction peacekeeping forces.
The Ebola virus causes viral hemorrhagic fever, which refers to a group of viruses that affect multiple organ systems in the body and are often accompanied by bleeding.
The experimental medicine is a three-mouse monoclonal antibody, meaning that mice were exposed to fragments of the Ebola virus and then the antibodies generated within the mice’s blood were harvested to create the medicine. It works by preventing the virus from entering and infecting new cells.
Developed by a San Diego Company, Mapp Biopharmaceutical, the experimental serum had never been tried before on human beings but had shown promise in small experiments with monkeys. Company documents show that four monkeys infected with Ebola survived after being given the therapy within 24 hours after infection.
In the monkeys, the experimental serum had been given within 48 hours of infection. Two of four other monkeys that started therapy within 48 hours after infection also survived. One monkey that was not treated died within five days of exposure to the virus.
Source:vanguardngr.com
Ad blocker detected: Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker on our website.
Ebola Latest: US Rejects Nigeria’s Request For Trial Drug
For non healthcare worker who wish to express opinion on nursing and hospital issues.
- Kunle Emmanuel
- Webmaster
- Reactions:
- Posts: 3332
- Joined: Mon Jan 09, 2012 5:02 pm
- Years of practice: 20
- Location: Lagos
- Contact:
Ebola Latest: US Rejects Nigeria’s Request For Trial Drug
Unread post by Kunle Emmanuel »
Together We Light Up The Profession one candle at a time.
-
- Similar Topics
- Replies
- Views
- Last post
-
-
The New UK Health and Care visa Latest Updates For Nurses
Replies: 7by Queenet » Fri Sep 11, 2020 11:40 am » in Nursing Related News & Articles - 7 Replies
- 4749 Views
-
Last post by hadiosd
Mon Nov 22, 2021 1:04 am
-
-
-
Latest Changes to the English Language requirements for International nursing vacancies in the UK.
by Kunle Emmanuel » Thu Nov 28, 2019 5:18 am » in Nursing Related News & Articles - 0 Replies
- 4572 Views
-
Last post by Kunle Emmanuel
Thu Nov 28, 2019 5:18 am
-
-
-
NURSE’S DRUG HANDBOOK FULL PDF
Replies: 1by Kunle Emmanuel » Mon Oct 25, 2021 8:48 am » in Free Nursing e-Book - 1 Replies
- 2162 Views
-
Last post by Alexjakson
Mon Oct 25, 2021 9:59 am
-
-
-
What is all about this ND Nursing in Nigeria?
by Kunle Emmanuel » Thu Apr 27, 2023 8:32 pm » in Student Nurses Discussion and News - 0 Replies
- 1283 Views
-
Last post by Kunle Emmanuel
Thu Apr 27, 2023 8:32 pm
-
-
-
How do I register for UK NMC CBT in Nigeria?
Replies: 5by Kunle Emmanuel » Sat Oct 31, 2020 1:43 pm » in Nursing Related News & Articles - 5 Replies
- 8627 Views
-
Last post by Kunle Emmanuel
Wed Jul 13, 2022 12:28 pm
-
Return to “Public Discussion Forum”
Jump to
- Announcements, Feedback & Support
- ↳ Welcome Message To All Visitors
- ↳ Announcement & Tutorial
- ↳ Forum Rules - Read Before Posting
- Nursing News
- ↳ Nursing Related News & Articles
- ↳ Nurse to Nurse Discussion
- ↳ General Health News
- ↳ Male Nurses
- ↳ Retired Nurses
- Jobs in Nursing and Healthcare
- ↳ Nursing Job & Recruitment
- MCPDP for Nurses & Midwives
- ↳ MCPDP for Nurses & Midwives
- ↳ Continuous Education
- Nursing Education
- ↳ Student Nurses Discussion and News
- ↳ Nursing Inspirations, Jokes, and Quotes
- Public Health Adviser
- ↳ Public Health Education
- ↳ Maternal & Child Health Education
- ↳ Sexual Health Education
- ↳ Public Discussion Forum
- Clinical Nursing Discussion
- ↳ Clinical Nursing Blog
- ↳ Specialty Nursing Discussion Forum
- ↳ Free Nursing e-Book
- ↳ MEDICAL EDUCATIONAL VIDEOS HD
- Nursing Digital Skill Empowerment Program
- ↳ Nursing Digital Skill Program
- Workplace Safety Forum
- ↳ Safety Health Enviroment SHE Topics
- Marketing Online
- ↳ Marketing Medical Products
Who is online
Users browsing this forum: No registered users and 25 guests